Medicus Sciences Acquisition Corp. (NASDAQ:MSAC) Sees Large Decrease in Short Interest

Medicus Sciences Acquisition Corp. (NASDAQ:MSACGet Rating) saw a large decrease in short interest in May. As of May 15th, there was short interest totalling 400 shares, a decrease of 63.6% from the April 30th total of 1,100 shares. Based on an average daily trading volume, of 36,400 shares, the short-interest ratio is presently 0.0 days.

Shares of NASDAQ:MSAC opened at $9.77 on Thursday. The business’s 50-day moving average is $9.80 and its 200 day moving average is $9.75. Medicus Sciences Acquisition has a 1 year low of $9.58 and a 1 year high of $9.85.

A number of large investors have recently made changes to their positions in MSAC. Sio Capital Management LLC acquired a new position in Medicus Sciences Acquisition during the 4th quarter valued at about $22,580,000. Cubist Systematic Strategies LLC acquired a new position in Medicus Sciences Acquisition during the 4th quarter valued at about $2,729,000. Centiva Capital LP acquired a new position in Medicus Sciences Acquisition during the 4th quarter valued at about $2,430,000. D. E. Shaw & Co. Inc. increased its holdings in shares of Medicus Sciences Acquisition by 133.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 402,255 shares of the company’s stock valued at $3,910,000 after purchasing an additional 230,190 shares during the period. Finally, Saba Capital Management L.P. increased its holdings in shares of Medicus Sciences Acquisition by 37.8% in the fourth quarter. Saba Capital Management L.P. now owns 817,821 shares of the company’s stock valued at $7,949,000 after purchasing an additional 224,300 shares during the period.

Medicus Sciences Acquisition Company Profile (Get Rating)

Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally.

Further Reading

Receive News & Ratings for Medicus Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.